Back to results
US 7,678,805 B2Granted
Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (IBD)
AssigneeScience Incorporated
InventorsAlain Moussy, Jean-Pierre Kinet
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for treating inflammatory bowel diseases (IBD), such as crohn's disease, comprising administering a tyrosine kinase inhibitor to a human in need of such treatment, more particularly a non-toxic, selective and potent c-kit inhibitor. Preferably, said inhibitor is unable to promote death of IL-3 dependent cells cultured in presence of IL-3.
Claims4
A method for treating inflammatory bowel diseases (IBD) comprising administering an effective amount of the following compound
- 4-(4-methylpiperazine-1-ylmethyl)-N-[4-methyl-3-[(4-pyridine-3-ylpyrimidine-2-yl)amino]phenyl]-benzamide, or a pharmaceutically acceptable salt thereof, to a human in need of such treatment.
Dependencies are inferred from the claim text.